This role is a rare opportunity to establish and lead a Peptide Process Development function from the ground up. The position involves building a Boston-based lab and team while providing global leadership across Drug Substance. The role owns the full arc from synthetic route scouting through Phase 1 and 2, laying the foundation for Phase 3-ready processes. It is central to enabling Zealand's growing pipeline of peptide therapeutics to reach patients. The Head of Drug Substance will establish and lead the Peptide Process Development lab in Boston, including hiring and developing a high-performing local team. They will provide global leadership and strategic direction for the Drug Substance function from early discovery to Phase 2. Responsibilities include leading synthetic route scouting and salt selection, evaluating alternative processes with yield, COGS, manufacturability, and scalability as key decision criteria. The role also involves developing and optimizing upstream and downstream process design to establish scalable, cost-effective synthetic routes fit for initial clinical trials and as the foundation for Phase 3. Close collaboration with Analytical Development and Manufacturing is required to ensure processes are scalable, robust, and sustainable. Driving technology transfer in collaboration with the DK drug substance team to external CMOs, ensuring seamless transition from development to production, is also a key aspect of the role.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree